AZD2373 subcutaneous injection for Healthy Subjects
This trial is testing a new drug to see if it is safe and well tolerated in healthy male participants of sub-Saharan West African ancestry. The study will also look at how the drug is processed by the body.
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Find a site
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Who meets the criteria to participate in this medical experiment?
"The trial is seeking around 40 participants who are between 18 and 55 years old, with healthy subjects (hs)."
Does this investigation include geriatric participants?
"This medical trial is available to patients aged 18-55 who meet the required criteria."
Are new participants being enrolled in this experiment currently?
"Indeed, clinicaltrials.gov confirms that this medical study is actively recruiting volunteers and was first posted on April 4th 2022. The most recent update of the experiment took place November 30th 2022 and 40 individuals are needed to be recruited from a single site."
What is the upper capacity for people participating in this medical experiment?
"Affirmative. Clinicaltrials.gov indicates that the specified trial is currently enrolling individuals, which commenced on April 4th 2022 and was last updated on November 30th of the same year. 40 patients are being accepted from a single medical centre."
Is the subcutaneous injection of AZD2373 considered secure for patients?
"Taking into account the limited efficacy and safety data available, our team at Power has assigned a score of 1 to AZD2373 subcutaneous injection."